As life science venture investors, industry connectors, and company founders, Longwood Fund identifies and supports novel technologies and the teams behind them – advancing today’s most promising science into tomorrow’s treatments for patients who need them most.
Longwood is a leading firm committed to both company creation and investing in companies through development.
We leverage our curated network of industry leaders across academia, medicine, pharma, biotech, and venture capital to inform every stage of our investing process: from identifying and evaluating cutting edge areas of science, determining potential benefits of new therapies to patients, assessing or building a clinical development plan, to validating a therapy’s commercial potential.
Companies founded by the Longwood team have developed 20+ marketed products and ~25 therapies in late-stage development. Two of those examples are:
